Summary for ARTG Entry:
SURLAX ORAL LIQUID lactulose 667 mg/mL bottle
ARTG entry for
Aspen Pharma Pty Ltd
34-36 Chandos Street,ST LEONARDS, NSW, 2065
ARTG Start Date
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
1. SURLAX ORAL LIQUID lactulose 667 mg/mL bottle
Single Medicine Product
No Warnings included on Record
Treatment of acute, and prevention and treatment of chronic portal-systemic encephalopathy (PSE), including the stages of hepatic pre-coma and
coma.,Treatment of chronic and habitual constipation.,Where a soft stool is considered of medical benefit (haemorrhoids, post-colonic/anal surgery).
Additional Product information
Store below 25
Pack Size/Poison information
Not scheduled. Not considered by committee
Route of Administration
Clear, colourless to brownish-yellow, viscous liquid.
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 26.11.2017 at 02:50:20 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information